BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yoshiji H, Nagoshi S, Akahane T, Asaoka Y, Ueno Y, Ogawa K, Kawaguchi T, Kurosaki M, Sakaida I, Shimizu M, Taniai M, Terai S, Nishikawa H, Hiasa Y, Hidaka H, Miwa H, Chayama K, Enomoto N, Shimosegawa T, Takehara T, Koike K. Evidence-based clinical practice guidelines for liver cirrhosis 2020. Hepatol Res 2021;51:725-49. [PMID: 34228859 DOI: 10.1111/hepr.13678] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Kakisaka K, Sato T, Wada Y, Ito A, Eto H, Abe H, Kanazawa J, Yusa K, Kooka Y, Endo K, Yoshida Y, Oikawa T, Kuroda H, Miyasaka A, Akasaka M, Matsumoto T. Lactulose: A treatment for hyperammonemia in a lysinuric protein-intolerant patient with dynamic blood amino acid concentrations. Mol Genet Metab Rep 2022;32:100898. [PMID: 35865266 DOI: 10.1016/j.ymgmr.2022.100898] [Reference Citation Analysis]
2 Philips CA, Kedarisetty CK. Palliative Care For Patients With End-Stage Liver Disease. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.08.003] [Reference Citation Analysis]
3 Moreno Traspas R, Teoh TS, Wong PM, Maier M, Chia CY, Lay K, Ali NA, Larson A, Al Mutairi F, Al-Sannaa NA, Faqeih EA, Alfadhel M, Cheema HA, Dupont J, Bézieau S, Isidor B, Low DY, Wang Y, Tan G, Lai PS, Piloquet H, Joubert M, Kayserili H, Kripps KA, Nahas SA, Wartchow EP, Warren M, Bhavani GS, Dasouki M, Sandoval R, Carvalho E, Ramos L, Porta G, Wu B, Lashkari HP, AlSaleem B, BaAbbad RM, Abreu Ferrão AN, Karageorgou V, Ordonez-Herrera N, Khan S, Bauer P, Cogne B, Bertoli-Avella AM, Vincent M, Girisha KM, Reversade B. Loss of FOCAD, operating via the SKI messenger RNA surveillance pathway, causes a pediatric syndrome with liver cirrhosis. Nat Genet 2022. [PMID: 35864190 DOI: 10.1038/s41588-022-01120-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Shigefuku R, Takahashi H, Watanabe T, Hattori N, Ikeda H, Matsunaga K, Ehira T, Suzuki T, Matsumoto N, Okuse C, Iwasa M, Nakagawa H, Itoh F, Suzuki M. Effects of endoscopic injection sclerotherapy for esophagogastric varices on portal hemodynamics and liver function. BMC Gastroenterol 2022;22:350. [PMID: 35864442 DOI: 10.1186/s12876-022-02422-7] [Reference Citation Analysis]
5 Okushin K, Tateishi R, Takahashi A, Uchino K, Nakagomi R, Nakatsuka T, Minami T, Sato M, Fujishiro M, Hasegawa K, Eguchi Y, Kanto T, Kubo S, Yoshiji H, Miyata H, Izumi N, Kudo M, Koike K. Current status of primary liver cancer and decompensated cirrhosis in Japan: launch of a nationwide registry for advanced liver diseases (REAL). J Gastroenterol 2022. [PMID: 35788887 DOI: 10.1007/s00535-022-01893-5] [Reference Citation Analysis]
6 Zhang X, Jain D. The many faces and pathologic diagnostic challenges of autoimmune hepatitis. Hum Pathol 2022:S0046-8177(22)00164-2. [PMID: 35753409 DOI: 10.1016/j.humpath.2022.06.019] [Reference Citation Analysis]
7 Tada T, Kurosaki M, Tamaki N, Yasui Y, Mori N, Tsuji K, Hasebe C, Joko K, Akahane T, Furuta K, Kobashi H, Fujii H, Ishii T, Marusawa H, Kondo M, Kojima Y, Yoshida H, Uchida Y, Nakamura S, Izumi N. General evaluation score for predicting the development of hepatocellular carcinoma in patients with advanced liver fibrosis associated with hepatitis C virus genotype 1 or 2 after direct‐acting antiviral therapy. JGH Open. [DOI: 10.1002/jgh3.12778] [Reference Citation Analysis]
8 [DOI: 10.7759/cureus.24676] [Reference Citation Analysis]
9 Kaibori M, Hiraoka A, Iida H, Komeda K, Hirokawa F, Ueno M, Kosaka H, Matsui K, Sekimoto M. Comparison of the New Neo-Glasgow Prognostic Score Based on the Albumin-Bilirubin Grade with Currently Used Nutritional Indices for Prognostic Prediction following Surgical Resection of Hepatocellular Carcinoma: A Multicenter Retrospective Study in Japan. Cancers (Basel) 2022;14:2091. [PMID: 35565221 DOI: 10.3390/cancers14092091] [Reference Citation Analysis]
10 Eso Y. Questionnaire-based approach to sleep-wake disturbance in patients with chronic liver disease. Hepatol Res 2022;52:327-8. [PMID: 35366385 DOI: 10.1111/hepr.13760] [Reference Citation Analysis]
11 Kawaratani H, Kondo Y, Tatsumi R, Kawabe N, Tanabe N, Sakamaki A, Okumoto K, Uchida Y, Endo K, Kawaguchi T, Oikawa T, Ishizu Y, Hige S, Takami T, Terai S, Ueno Y, Mochida S, Takikawa Y, Torimura T, Matsuura T, Ishigami M, Koike K, Yoshiji H. Long-Term Efficacy and Safety of Rifaximin in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study. JCM 2022;11:1571. [DOI: 10.3390/jcm11061571] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Kaibori M, Hiraoka A, Matsui K, Matsushima H, Kosaka H, Yamamoto H, Yamaguchi T, Yoshida K, Sekimoto M. Predicting Complications following Surgical Resection of Hepatocellular Carcinoma Using Newly Developed Neo-Glasgow Prognostic Score with ALBI Grade: Comparison of Open and Laparoscopic Surgery Cases. Cancers (Basel) 2022;14:1402. [PMID: 35326554 DOI: 10.3390/cancers14061402] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Tatsumi A, Maekawa S, Osawa L, Katoh R, Komiyama Y, Nakakuki N, Takada H, Matsuda S, Muraoka M, Suzuki Y, Sato M, Takahashi E, Miura M, Amemiya F, Takano S, Fukasawa M, Yamaguchi T, Nakayama Y, Inoue T, Okada H, Araki T, Onishi H, Enomoto N. Spontaneous portosystemic shunt diameter predicts liver function after balloon‐occluded retrograde transvenous obliteration. JGH Open. [DOI: 10.1002/jgh3.12712] [Reference Citation Analysis]
14 Tada T, Kurosaki M, Tamaki N, Yasui Y, Mori N, Tsuji K, Hasebe C, Joko K, Akahane T, Furuta K, Kobashi H, Kimura H, Yagisawa H, Marusawa H, Kondo M, Kojima Y, Yoshida H, Uchida Y, Nakamura S, Izumi N. A validation study of after direct-acting antivirals recommendation for surveillance score for the development of hepatocellular carcinoma in patients with hepatitis C virus infection who had received direct-acting antiviral therapy and achieved sustained virological response. JGH Open 2022;6:20-8. [PMID: 35071784 DOI: 10.1002/jgh3.12690] [Reference Citation Analysis]
15 Ikegami T, Nishikawa H, Goto M, Matsui M, Asai A, Ushiro K, Ogura T, Takeuchi T, Nakamura S, Kakimoto K, Miyazaki T, Fukunishi S, Ohama H, Yokohama K, Yasuoka H, Higuchi K. The Relationship between the SARC-F Score and the Controlling Nutritional Status Score in Gastrointestinal Diseases. JCM 2022;11:582. [DOI: 10.3390/jcm11030582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Kamimura H, Imai M, Abe H, Yoshioka A, Hirose K, Ishihara N, Ishikawa T, Terai S. Simultaneous muscular hemorrhages in two regions three years after successfully controlling refractory ascites using transjugular intrahepatic portosystemic shunt treatment: a case report. Clin J Gastroenterol 2022. [PMID: 35038137 DOI: 10.1007/s12328-022-01591-y] [Reference Citation Analysis]
17 Takaya H, Namisaki T, Matsumoto K, Suzuki J, Murata K, Tsuji Y, Nakanishi K, Kaji K, Kitade M, Noguchi R, Yoshiji H. Comparison of Ablation Area and Change in Functional Liver Reserve after Radiofrequency Ablation for Hepatocellular Carcinoma Using the arfa® and VIVA® Systems. J Clin Med 2022;11:434. [PMID: 35054128 DOI: 10.3390/jcm11020434] [Reference Citation Analysis]
18 Yoshida M, Tateishi R, Hiroi S, Hongo Y, Fujiwara M, Kitanishi Y, Iwasaki K, Takeshima T, Igarashi A. Effects of Lusutrombopag on Post-invasive Procedural Bleeding in Thrombocytopenic Patients with Chronic Liver Disease. Adv Ther 2022;39:379-90. [PMID: 34748184 DOI: 10.1007/s12325-021-01965-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Ogawa Y, Nakahara T, Ono M, Kawaguchi T, Isoda H, Hiramatsu A, Uchikawa S, Fujino H, Murakami E, Kawaoka T, Yamauchi M, Tsuge M, Munekage K, Ochi T, Hayes CN, Imamura M, Aikata H, Takahashi H, Torimura T, Chayama K. Underestimation of impaired glucose tolerance and usefulness of a continuous glucose monitoring system in chronic liver disease. J Gastroenterol Hepatol 2021. [PMID: 34928509 DOI: 10.1111/jgh.15766] [Reference Citation Analysis]
20 Akahane T. Factors associated with portopulmonary hypertension. Hepatol Res 2021;51:1179-80. [PMID: 34850499 DOI: 10.1111/hepr.13721] [Reference Citation Analysis]
21 Hayashi S, Nagaoka K, Tanaka Y. Blood-Based Biomarkers in Hepatitis B Virus-Related Hepatocellular Carcinoma, Including the Viral Genome and Glycosylated Proteins. Int J Mol Sci 2021;22:11051. [PMID: 34681709 DOI: 10.3390/ijms222011051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Yamana H, Imai S, Yamasaki K, Horiguchi H, Ario K, Komatsu T, Sugimoto R, Katsushima S, Naganuma A, Mano Y, Yamashita T, Kamitsukasa H, Tsuruta S, Jo T, Yasunaga H, Fushimi K, Yatsuhashi H. Prognosis of patients with liver cirrhosis: A multi-center retrospective observational study. Hepatol Res 2021. [PMID: 34492143 DOI: 10.1111/hepr.13711] [Reference Citation Analysis]